RxDoctor Payments DataLook up a doctor →

Kristine Starcevich

Adult Health · Merrillville, INNPI 1437326881

Payments from drug & device makers

$18,927in general payments, 2019–2025

Across 789 payments — averaging $23.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2K
  • Jazz Pharmaceuticals Inc.$1K
  • AbbVie$1K
  • Novartis$1K
  • Avadel CNS Pharmaceuticals, LLC$980
  • Livanova USA, Inc.$784
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen77$2,342
Jazz Pharmaceuticals Inc.55$1,455
AbbVie(2 entities)102$1,371
Novartis81$1,177
Avadel CNS Pharmaceuticals, LLC24$980
Livanova USA, Inc.13$784
Teva Pharmaceuticals USA, Inc.36$764
Johnson & Johnson(2 entities)21$595
Neurocrine Biosciences, Inc.10$588
Bristol Myers Squibb22$559
AstraZeneca14$532
Otsuka America Pharmaceutical, Inc.15$525
EMD Serono, Inc.12$494
Lilly USA, LLC22$477
Axsome Therapeutics, Inc.16$450
SK Life Science, Inc.21$421
Amgen12$410
Lundbeck LLC20$393
TG Therapeutics, Inc.13$391
Acadia Pharmaceuticals Inc19$365
Acorda Therapeutics, Inc19$356
UCB, Inc.15$330
Argenx US, Inc.13$263
Inspire Medical Systems, Inc.2$239
Pfizer17$208
Kyowa Kirin, Inc.3$197
Harmony Biosciences LLC9$177
Neurelis, Inc.5$171
Takeda Pharmaceuticals U.S.A., Inc.11$160
Merz Pharmaceuticals, LLC7$151
Catalyst Pharmaceuticals, Inc.8$143
Sanofi2$141
Merz North America, Inc.2$140
Corium, LLC6$124
Genentech USA, Inc.8$120
Banner Life Sciences, LLC6$101
Supernus Pharmaceuticals, Inc.4$64
Eisai Inc.3$61
Amneal Pharmaceuticals LLC4$57
Otsuka Pharmaceutical Development & Commercialization, Inc.2$51
Tanabe Pharma America, Inc.3$45
Springworks Therapeutics, Inc.2$44
Aucta Pharmaceuticals, Inc.2$44
Avion Pharmaceuticals2$43
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$39
Bausch Health US, LLC3$37
Impel Pharmaceuticals LLC3$35
Adamas Pharmaceuticals, Inc.2$32
Scilex Pharmaceuticals Inc.2$30
Impel Pharmaceuticals Inc.2$28
E.r. Squibb & Sons, L.L.C.1$26
Biohaven Pharmaceuticals, Inc.2$23
ANI Pharmaceuticals, Inc.1$22
Cycle Pharmaceuticals Inc1$18
Merck1$17
Akcea Therapeutics, Inc.1$16
Tris Pharma Inc1$15
Cala Health, Inc.1$15
Ironshore Pharmaceuticals Inc.1$14
Ipsen Biopharmaceuticals, Inc1$13

How this compares

$18,927 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana →

Medicare billing

Part B allowed, 2024
$114,186
Medicare patients
410
Services billed
6,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Merrillville

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →